{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:19:40Z","timestamp":1790961580986,"version":"4.1.0"},"reference-count":233,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["64964"],"award-info":[{"award-number":["64964"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.intimp.2022.108682","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T12:51:20Z","timestamp":1646484680000},"page":"108682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["NK cells - Dr. Jekyll and Mr. Hyde in autoimmune rheumatic diseases"],"prefix":"10.1016","volume":"107","author":[{"given":"Tahereh","family":"Hojjatipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevda","family":"Salimifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleh","family":"Mikaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hemmatzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid","family":"Gholizadeh Navashenaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Ahangar Parvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Jadidi-Niaragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.108682_b0005","doi-asserted-by":"crossref","unstructured":"A. Abel, C. Yang, M. Thakar, S. Malarkannan, Natural Killer Cells: Development, Maturation, and Clinical Utilization Immunobiology of NK Cells 9 (2018).","DOI":"10.3389\/fimmu.2018.01869"},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b0010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","article-title":"Human NK cells: surface receptors, inhibitory checkpoints, and translational applications","volume":"16","author":"Sivori","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2022.108682_b0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.ai.2019.11.002","article-title":"Tissue-resident NK cells and other innate lymphoid cells","volume":"145","author":"Zhou","year":"2020","journal-title":"Adv. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41423-018-0192-y","article-title":"Tissue-resident lymphocytes: from adaptive to innate immunity","volume":"16","author":"Sun","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.autrev.2017.11.018","article-title":"NK cells in autoimmune diseases: Linking innate and adaptive immune responses","volume":"17","author":"Gianchecchi","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0030","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/1521-4141(200203)32:3<879::AID-IMMU879>3.0.CO;2-2","article-title":"Human NK1 and NK2 subsets determined by purification of IFN-\u03b3-secreting and IFN-\u03b3-nonsecreting NK cells","volume":"32","author":"Deniz","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0035","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4049\/jimmunol.180.2.850","article-title":"Regulatory NK cells suppress antigen-specific T cell responses","volume":"180","author":"Deniz","year":"2008","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaut.2012.05.006","article-title":"Regulatory NK cells in autoimmune disease","volume":"39","author":"Tian","year":"2012","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/08820139.2017.1288240","article-title":"Natural killer cell subsets and their functional activity in Beh\u00e7et\u2019s disease","volume":"46","author":"Cosan","year":"2017","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.intimp.2022.108682_b0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clim.2018.02.005","article-title":"Dysfunction of CD3\u2212 CD16+ CD56dim and CD3\u2212 CD16\u2212 CD56bright NK cell subsets in RR-MS patients","volume":"193","author":"Tahrali","year":"2018","journal-title":"Clinical Immunology"},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1586\/eci.09.27","article-title":"Natural killer cells: versatile roles in autoimmune and infectious diseases","volume":"5","author":"Aktas","year":"2009","journal-title":"Expert review of clinical immunology"},{"key":"10.1016\/j.intimp.2022.108682_b0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2021.622306","article-title":"The role of natural killer cells in autoimmune diseases","volume":"12","author":"Kucuksezer","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0065","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.immuni.2015.07.011","article-title":"Identification of a human natural killer cell lineage-restricted progenitor in fetal and adult tissues","volume":"43","author":"Renoux","year":"2015","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0070","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1084\/jem.20052507","article-title":"Evidence for discrete stages of human natural killer cell differentiation in vivo","volume":"203","author":"Freud","year":"2006","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cyto.a.22025","article-title":"Cytotoxic functions and susceptibility to apoptosis of human CD56bright NK cells differentiated in vitro from CD34+ hematopoietic progenitors","volume":"81","author":"Zamai","year":"2012","journal-title":"Cytometry Part A"},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0080","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/cells9030753","article-title":"Understanding the synergy of NKp46 and co-activating signals in various NK cell subpopulations: paving the way for more successful NK-cell-based immunotherapy","volume":"9","author":"Zamai","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.intimp.2022.108682_b0085","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000382019","article-title":"Human cytokine-induced memory-like natural killer cells","volume":"7","author":"Berrien-Elliott","year":"2015","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.intimp.2022.108682_b0090","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"Fehniger TA, and Caligiuri MA, The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"issue":"8","key":"10.1016\/j.intimp.2022.108682_b0095","first-page":"3052","article-title":"CD56bright natural killer cells are present in human lymph nodes and are activated by T cell\u2013derived IL-2: a potential new link between adaptive and innate immunity","volume":"101","author":"Fehniger","year":"2003","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"6","key":"10.1016\/j.intimp.2022.108682_b0100","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1073\/pnas.1016257108","article-title":"CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells","volume":"108","author":"Vacca","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b0105","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The broad spectrum of human natural killer cell diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.intimp.2022.108682_b0110","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4","article-title":"CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells","volume":"31","author":"Jacobs","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b0115","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/eji.200940056","article-title":"Murine CXCR3+ CD27bright NK cells resemble the human CD56bright NK-cell population","volume":"40","author":"Marquardt","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-14471-0","article-title":"Evaluating anthropogenic threats to endangered killer whales to inform effective recovery plans","volume":"7","author":"Lacy","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2022.108682_b0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00281-018-0688-7","article-title":"The roles for innate lymphoid cells in the human immune system","author":"Mazzurana","year":"2018","journal-title":"Seminars in Immunopathology, Springer"},{"issue":"7","key":"10.1016\/j.intimp.2022.108682_b0130","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ni.3481","article-title":"Development of innate lymphoid cells","volume":"17","author":"Zook","year":"2016","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0135","first-page":"1273","article-title":"Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells","volume":"99","author":"Loza","year":"2002","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b0140","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jaci.2016.09.011","article-title":"Innate lymphoid cells in allergic and nonallergic inflammation","volume":"138","author":"Morita","year":"2016","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b0145","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4110\/in.2017.17.5.352","article-title":"Functional defects in type 3 innate lymphoid cells and classical monocytes in a patient with hyper-ige syndrome","volume":"17","author":"Chang","year":"2017","journal-title":"Immune Network"},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0150","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0155","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1073\/pnas.1012356108","article-title":"Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN-\u03b3 on activation","volume":"108","author":"De Maria","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b0160","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ceb.2008.05.006","article-title":"The killer's kiss: the many functions of NK cell immunological synapses","volume":"20","author":"Krzewski","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5114\/ceji.2014.42135","article-title":"Perforin: an important player in immune response","volume":"39","author":"Osi\u0144ska","year":"2014","journal-title":"Central-European journal of immunology"},{"issue":"9","key":"10.1016\/j.intimp.2022.108682_b0170","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.4049\/jimmunol.1701500","article-title":"Single degranulations in NK cells can mediate target cell killing","volume":"200","author":"Gwalani","year":"2018","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2022.108682_b0175","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/MCB.20.11.3781-3794.2000","article-title":"Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid","volume":"20","author":"Barry","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"33","key":"10.1016\/j.intimp.2022.108682_b0180","doi-asserted-by":"crossref","first-page":"21298","DOI":"10.1074\/jbc.273.33.21298","article-title":"Activation of gene expression by a novel DNA structural transmission mechanism that requires supercoiling-induced DNA duplex destabilization in an upstream activating sequence","volume":"273","author":"Sheridan","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1084\/jem.188.1.119","article-title":"Spontaneous skin ulceration and defective T cell function in CD18 null mice","volume":"188","author":"Scharffetter-Kochanek","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2022.108682_b0190","article-title":"Caspase-8 regulation of TRAIL-mediated cell death","author":"Crowder","year":"2012","journal-title":"Experimental oncology"},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031959","article-title":"Cytotoxicity of CD56bright NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94\/NKG2A","volume":"7","author":"Nielsen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.108682_b0200","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jaut.2016.04.003","article-title":"Dysregulation of regulatory CD56bright NK cells\/T cells interactions in multiple sclerosis","volume":"72","author":"Laroni","year":"2016","journal-title":"J. Autoimmun."},{"issue":"15","key":"10.1016\/j.intimp.2022.108682_b0205","first-page":"4052","article-title":"Development of IL-22\u2013producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue","volume":"117","author":"Tang","year":"2011","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.intimp.2022.108682_b0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.imlet.2019.10.006","article-title":"CD3-CD56+ NK cells display an inflammatory profile in RR-MS patients","volume":"216","author":"Tahrali","year":"2019","journal-title":"Immunol. Lett."},{"issue":"12","key":"10.1016\/j.intimp.2022.108682_b0215","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ni1138","article-title":"Induced recruitment of NK cells to lymph nodes provides IFN-\u03b3 for TH 1 priming","volume":"5","author":"Mart\u00edn-Fontecha","year":"2004","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0220","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2249.1995.tb03143.x","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) counteracts the inhibiting effect of monocytes on natural killer (NK) cells","volume":"101","author":"Van den Bosch","year":"1995","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2022.108682_b0225","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood-2005-03-1154","article-title":"Natural-killer cells and dendritic cells:\u201cl'union fait la force\u201d","volume":"106","author":"Walzer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2022.108682_b0230","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev-immunol-042617-053149","article-title":"Genetics of natural killer cells in human health, disease, and survival","volume":"36","author":"Parham","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.108682_b0235","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.4049\/jimmunol.134.6.3798","article-title":"Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid)","volume":"134","author":"Dorshkind","year":"1985","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","article-title":"MHC class I molecules and KIRs in human history, health and survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2022.108682_b0245","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.173.7.4273","article-title":"Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection\/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis","volume":"173","author":"Nelson","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2022.108682_b0250","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1376595","article-title":"The memories of NK cells: innate-adaptive immune intrinsic crosstalk","volume":"2016","author":"Gabrielli","year":"2016","journal-title":"Journal of immunology research"},{"key":"10.1016\/j.intimp.2022.108682_b0255","doi-asserted-by":"crossref","unstructured":"S. Hiby, J. Walker, M. O'Shaughnessy K, CW Redman, M. Carrington, J. Trowsdale, and A. Moffett. 2004. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success, J. Exp. Med 200 957-965.","DOI":"10.1084\/jem.20041214"},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0260","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"Anfossi","year":"2006","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0265","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0270","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.molimm.2004.07.034","article-title":"Activation of NK cell cytotoxicity","volume":"42","author":"Smyth","year":"2005","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2022.108682_b0275","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.190.10.1505","article-title":"Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells","volume":"190","author":"Pende","year":"1999","journal-title":"J. Exp. Med."},{"issue":"5428","key":"10.1016\/j.intimp.2022.108682_b0280","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.intimp.2022.108682_b0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fimmu.2014.00105","article-title":"TLR\/NCR\/KIR: which one to use and when?","volume":"5","author":"Sivori","year":"2014","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0290","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/icb.2017.6","article-title":"Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells","volume":"95","author":"Ochoa","year":"2017","journal-title":"Immunol. Cell Biol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0295","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.alit.2020.08.002","article-title":"Mechanisms of allergen-specific immunotherapy and allergen tolerance","volume":"69","author":"Kucuksezer","year":"2020","journal-title":"Allergology International"},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b0300","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.gie.2006.07.049","article-title":"One-step, simultaneous double-wire technique facilitates pancreatic pseudocyst and abscess drainage (with videos)","volume":"64","author":"Seewald","year":"2006","journal-title":"Gastrointest. Endosc."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms7375","article-title":"Generation of cellular immune memory and B-cell immunity is impaired by natural killer cells","volume":"6","author":"Rydyznski","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031615","article-title":"Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans","volume":"7","author":"Lian","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0315","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4049\/jimmunol.1500591","article-title":"CD56brightCD16\u2212 NK cells produce adenosine through a CD38-mediated pathway and act as regulatory cells inhibiting autologous CD4+ T cell proliferation","volume":"195","author":"Morandi","year":"2015","journal-title":"J. Immunol."},{"issue":"6230","key":"10.1016\/j.intimp.2022.108682_b0320","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.aaa4972","article-title":"Cancer and the microbiota","volume":"348","author":"Garrett","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.intimp.2022.108682_b0325","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fimmu.2017.00760","article-title":"NK cell exhaustion","volume":"8","author":"Bi","year":"2017","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2022.108682_b0330","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI45816","article-title":"Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity","volume":"121","author":"Mamessier","year":"2011","journal-title":"J. Clin. Investig."},{"issue":"16","key":"10.1016\/j.intimp.2022.108682_b0335","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1158\/0008-5472.CAN-10-4179","article-title":"Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma","volume":"71","author":"Platonova","year":"2011","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.intimp.2022.108682_b0340","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1182\/blood-2006-04-020198","article-title":"Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells","volume":"108","author":"Grzywacz","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-11-262","article-title":"Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer","volume":"11","author":"Peng","year":"2013","journal-title":"Journal of translational medicine"},{"issue":"42","key":"10.1016\/j.intimp.2022.108682_b0350","doi-asserted-by":"crossref","first-page":"68513","DOI":"10.18632\/oncotarget.12097","article-title":"NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma","volume":"7","author":"Parry","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0355","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/eji.201141832","article-title":"Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD","volume":"42","author":"Wiesmayr","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"45","key":"10.1016\/j.intimp.2022.108682_b0360","doi-asserted-by":"crossref","first-page":"72961","DOI":"10.18632\/oncotarget.12150","article-title":"PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma","volume":"7","author":"Beldi-Ferchiou","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0365","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/2326-6066.CIR-13-0133","article-title":"PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection","volume":"2","author":"MacFarlane","year":"2014","journal-title":"Cancer immunology research"},{"key":"10.1016\/j.intimp.2022.108682_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106594","article-title":"How microRNAs affect the PD-L1 and its synthetic pathway in cancer","volume":"84","author":"Danbaran","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2022.108682_b0375","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/iub.2558","article-title":"PD-1\/PD-L1 blockade: Prospectives for immunotherapy in cancer and autoimmunity","volume":"73","author":"Hosseinzadeh","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.intimp.2022.108682_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577061","article-title":"The role of immune regulatory molecules in multiple sclerosis","volume":"337","author":"Afshar","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0385","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2012.10.039","article-title":"Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice","volume":"144","author":"Li","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2022.108682_b0390","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1264562","article-title":"High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer","volume":"6","author":"Sun","year":"2017","journal-title":"Oncoimmunology"},{"issue":"9894","key":"10.1016\/j.intimp.2022.108682_b0395","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","article-title":"Clinical aspects of autoimmune rheumatic diseases","volume":"382","author":"Goldblatt","year":"2013","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0400","first-page":"816","article-title":"Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD","volume":"26","author":"Williams","year":"1999","journal-title":"The Journal of rheumatology"},{"key":"10.1016\/j.intimp.2022.108682_b0405","doi-asserted-by":"crossref","unstructured":"Y. Alamanos, P.V. Voulgari, A.A. Drosos, Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review, Seminars in arthritis and rheumatism, Elsevier, 2006, pp. 182-188.","DOI":"10.1016\/j.semarthrit.2006.08.006"},{"issue":"11","key":"10.1016\/j.intimp.2022.108682_b0410","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/1744666X.2017.1384312","article-title":"Autoimmunity in a cohort of 471 patients with primary antibody deficiencies","volume":"13","author":"Azizi","year":"2017","journal-title":"Expert review of clinical immunology"},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0415","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2353\/ajpath.2008.071008","article-title":"Sex differences in autoimmune disease from a pathological perspective","volume":"173","author":"Fairweather","year":"2008","journal-title":"The American journal of pathology"},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2591","article-title":"Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study","volume":"11","author":"Sokka","year":"2009","journal-title":"Arthritis research & therapy"},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-7-325","article-title":"The Autoimmune Disease Database: a dynamically compiled literature-derived database","volume":"7","author":"Karopka","year":"2006","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.intimp.2022.108682_b0430","first-page":"1","article-title":"The role of the IL-33\/ST2 immune pathway in autoimmunity: new insights and perspectives","author":"Ramezani","year":"2021","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.intimp.2022.108682_b0435","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"A patog\u00eanese da artrite reumat\u00f3ide","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2022.108682_b0440","unstructured":"R. Mohammed, A. Goyal, P. Bansal, Hand and Wrist Rheumatoid Arthritis, (2020)."},{"issue":"13","key":"10.1016\/j.intimp.2022.108682_b0445","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0450","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/cei.12891","article-title":"Association of NKG2D gene variants with susceptibility and severity of rheumatoid arthritis","volume":"187","author":"Mariaselvam","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b0455","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/genes11050492","article-title":"Differentially expressed genes of natural killer cells can distinguish rheumatoid arthritis patients from healthy controls","volume":"11","author":"Elemam","year":"2020","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0460","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.imlet.2010.11.001","article-title":"The role of Natural Killer cells in the pathogenesis of rheumatoid arthritis: major contributors or essential homeostatic modulators?","volume":"136","author":"Ahern","year":"2011","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.intimp.2022.108682_b0465","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3899\/jrheum.150644","article-title":"Altered natural killer cell subsets in seropositive arthralgia and early rheumatoid arthritis are associated with autoantibody status","volume":"43","author":"Chalan","year":"2016","journal-title":"The Journal of rheumatology"},{"issue":"8","key":"10.1016\/j.intimp.2022.108682_b0470","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10067-014-2641-z","article-title":"Role of cytolytic impairment of natural killer and natural killer T-cell populations in rheumatoid arthritis","volume":"33","author":"Aggarwal","year":"2014","journal-title":"Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.intimp.2022.108682_b0475","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1002\/art.23760","article-title":"Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production","volume":"58","author":"Lo","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"29","key":"10.1016\/j.intimp.2022.108682_b0480","doi-asserted-by":"crossref","first-page":"13028","DOI":"10.1073\/pnas.1000546107","article-title":"Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis","volume":"107","author":"S\u00f6derstr\u00f6m","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0485","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.humimm.2017.02.006","article-title":"Impaired NK cell functionality and increased TNF-\u03b1 production as biomarkers of chronic chikungunya arthritis and rheumatoid arthritis","volume":"78","author":"Thanapati","year":"2017","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0490","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1084\/jem.20010938","article-title":"Reciprocal activating interaction between natural killer cells and dendritic cells","volume":"195","author":"Gerosa","year":"2002","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0495","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1084\/jem.20010934","article-title":"Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells","volume":"195","author":"Piccioli","year":"2002","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.intimp.2022.108682_b0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007444","article-title":"Macrophage activation by IFN-\u03b3 triggers restriction of phagosomal copper from intracellular pathogens","volume":"14","author":"Shen","year":"2018","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.intimp.2022.108682_b0505","first-page":"1763","article-title":"A subset of natural killer cells is greatly expanded within inflamed joints, Arthritis & Rheumatism: Official Journal of the American College of","volume":"46","author":"Dalbeth","year":"2002","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0510","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bbrc.2009.06.120","article-title":"Tumor necrosis factor-\u03b1 enhances IL-15-induced natural killer cell differentiation","volume":"386","author":"Lee","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0515","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S8756-3282(01)00682-2","article-title":"Involvement of receptor activator of NF\u03baB ligand and tumor necrosis factor-\u03b1 in bone destruction in rheumatoid arthritis","volume":"30","author":"Romas","year":"2002","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.intimp.2022.108682_b0520","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1182\/blood-2002-11-3392","article-title":"IL-15 is an essential mediator of peripheral NK-cell homeostasis","volume":"101","author":"Ranson","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.intimp.2022.108682_b0525","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/art.27622","article-title":"Role of Th17 cells in human autoimmune arthritis","volume":"62","author":"Leipe","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"6812","key":"10.1016\/j.intimp.2022.108682_b0530","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","article-title":"T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-\u03b3","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.intimp.2022.108682_b0535","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17\u2013producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0540","first-page":"1","article-title":"Phenotypic and functional characterization of natural killer cells in rheumatoid arthritis-regulation with interleukin-15","volume":"10","author":"Lin","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0545","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/s10165-009-0160-6","article-title":"A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis","volume":"19","author":"Aramaki","year":"2009","journal-title":"Mod. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0550","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00296-008-0719-0","article-title":"NK and NKT cell dynamics after rituximab therapy for systemic lupus erythematosus and rheumatoid arthritis","volume":"29","author":"Reis","year":"2009","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0555","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/art.21617","article-title":"Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis","volume":"54","author":"Leandro","year":"2006","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0560","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/03009748809098768","article-title":"Effects of piroxicam and D-penicillamine on T lymphocyte subpopulations, natural killer cells and rheumatoid factor production in rheumatoid arthritis","volume":"17","author":"Thoen","year":"1988","journal-title":"Scand. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0565","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12016-012-8342-y","article-title":"Vitamin D in systemic and organ-specific autoimmune diseases","volume":"45","author":"Agmon-Levin","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.108682_b0570","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2022.108682_b0575","unstructured":"A.A. Justiz Vaillant, A. Goyal, P. Bansal, M. Varacallo, Systemic Lupus Erythematosus, StatPearls, StatPearls Publishing Copyright \u00a9 2021, StatPearls Publishing LLC., Treasure Island (FL), 2021."},{"key":"10.1016\/j.intimp.2022.108682_b0580","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.biopha.2016.12.072","article-title":"Epigenetic modifications and epigenetic based medication implementations of autoimmune diseases","volume":"87","author":"Ahmadi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2022.108682_b0585","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clim.2016.08.010","article-title":"Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis","volume":"185","author":"Mistry","year":"2017","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.intimp.2022.108682_b0590","doi-asserted-by":"crossref","unstructured":"D. Isenberg, J. Manson, M. Ehrenstein, A. Rahman, Fifty years of anti-ds DNA antibodies: are we approaching journey's end?, (2007).","DOI":"10.1093\/rheumatology\/kem112"},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0595","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/imm.12504","article-title":"Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus","volume":"146","author":"Mackern-Oberti","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2022.108682_b0600","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fimmu.2019.00772","article-title":"Innate immune cells' contribution to systemic lupus erythematosus","volume":"10","author":"Herrada","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.108682_b0605","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41423-019-0244-y","article-title":"CXCR4 and CXCR5 orchestrate dynamic germinal center reactions and may contribute to the pathogenesis of systemic lupus erythematosus","volume":"16","author":"Wu","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0610","first-page":"155","article-title":"The development of autoimmunity in C57BL\/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation","volume":"177","author":"Takeda","year":"1993","journal-title":"B cell immunoglobulin secretion, and autoimmune symptoms, J Exp Med"},{"issue":"9","key":"10.1016\/j.intimp.2022.108682_b0615","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/096120339700600905","article-title":"Lack of NK cells in lupus patients with renal involvement","volume":"6","author":"Erkeller-Yuksel","year":"1997","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b0620","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1191\/096120300678828460","article-title":"Down-regulation of natural killer cells and of g\/d T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?","volume":"9","author":"Riccieri","year":"2000","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0625","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10067-020-05306-x","article-title":"Activation status of CD56 dim natural killer cells is associated with disease activity of patients with systemic lupus erythematosus","volume":"40","author":"Liu","year":"2021","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0630","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1189\/jlb.4RU0315-081RR","article-title":"Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus","volume":"98","author":"Spada","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2022.108682_b0635","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.4049\/jimmunol.1000569","article-title":"Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosus","volume":"186","author":"Huang","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0640","doi-asserted-by":"crossref","first-page":"F207","DOI":"10.1152\/ajprenal.00482.2009","article-title":"Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models","volume":"299","author":"Nakatani","year":"2010","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0645","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cytogfr.2007.10.006","article-title":"Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history","volume":"19","author":"Fitzgerald-Bocarsly","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0650","first-page":"171","article-title":"A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus","volume":"23","author":"Yabuhara","year":"1996","journal-title":"The Journal of rheumatology"},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0655","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2249.2005.02822.x","article-title":"Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients","volume":"141","author":"Green","year":"2005","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2022.108682_b0660","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.4049\/jimmunol.1003349","article-title":"IFN-\u03b1 production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1\u03b2 and LFA-1","volume":"186","author":"Hagberg","year":"2011","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.108682_b0665","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/art.24686","article-title":"Regulation of the interferon-\u03b1 production induced by RNA-containing immune complexes in plasmacytoid dendritic cells","volume":"60","author":"Eloranta","year":"2009","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"6","key":"10.1016\/j.intimp.2022.108682_b0670","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/art.30313","article-title":"Phenotype and function of natural killer cells in systemic lupus erythematosus: Excess interferon-\u03b3 production in patients with active disease","volume":"63","author":"Hervier","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2022.108682_b0675","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.intimp.2022.108682_b0680","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3389\/fimmu.2019.02164","article-title":"Autoantibodies to killer cell immunoglobulin-like receptors in patients with systemic lupus erythematosus induce natural killer cell hyporesponsiveness","volume":"10","author":"Segerberg","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.108682_b0685","doi-asserted-by":"crossref","unstructured":"N. Hagberg, J. Theorell, K. Hjorton, M.-L. Eloranta, Y. Bryceson, L. R\u00f6nnblom, Autoantibodies to the CD94\/NKG2A and CD94\/NKG2C receptors in patients with systemic lupus erythematosus, (2014).","DOI":"10.1002\/art.38999"},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0690","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10067-009-1322-9","article-title":"Assay of T-and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus","volume":"29","author":"Li","year":"2010","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0695","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/03009742.2011.648657","article-title":"Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases","volume":"41","author":"Puxeddu","year":"2012","journal-title":"Scand. J. Rheumatol."},{"issue":"9","key":"10.1016\/j.intimp.2022.108682_b0700","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.4049\/jimmunol.1700588","article-title":"Downregulation of CD3\u03b6 in NK cells from systemic lupus erythematosus patients confers a proinflammatory phenotype","volume":"200","author":"Su\u00e1rez-Fueyo","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2022.108682_b0705","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4236562","article-title":"Cytotoxic function and cytokine production of natural killer cells and natural killer T-like cells in systemic lupus erythematosis regulation with interleukin-15","volume":"2019","author":"Lin","year":"2019","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0710","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/cei.13263","article-title":"Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus","volume":"196","author":"Hudspeth","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2022.108682_b0715","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2014.02.003","article-title":"IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice","volume":"53","author":"Hodge","year":"2014","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.intimp.2022.108682_b0720","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s10067-018-4138-7","article-title":"Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity","volume":"37","author":"Liu","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0725","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12016-008-8074-1","article-title":"Rituximab: beyond simple B cell depletion","volume":"34","author":"Kessel","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0730","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/FOC\/2008\/24\/1\/E2","article-title":"A review of the pathogenesis of ankylosing spondylitis","volume":"24","author":"Dakwar","year":"2008","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.intimp.2022.108682_b0735","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biopha.2018.01.108","article-title":"Immune cells involved in the pathogenesis of ankylosing spondylitis","volume":"100","author":"Rezaiemanesh","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.intimp.2022.108682_b0740","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.3899\/jrheum.070839","article-title":"Intracytoplasmic cytokine expression and T cell subset distribution in the peripheral blood of patients with ankylosing spondylitis","volume":"35","author":"Szanto","year":"2008","journal-title":"The Journal of rheumatology"},{"key":"10.1016\/j.intimp.2022.108682_b0745","doi-asserted-by":"crossref","unstructured":"N. Azuz-Lieberman, G. Markel, S.a. Mizrahi, R. Gazit, J. Hanna, H. Achdout, R. Gruda, G. Katz, T.I. Arnon, S. Battat, The involvement of NK cells in ankylosing spondylitis, International immunology 17(7) (2005) 837-845.","DOI":"10.1093\/intimm\/dxh270"},{"issue":"6","key":"10.1016\/j.intimp.2022.108682_b0750","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/art.24556","article-title":"Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus","volume":"60","author":"Park","year":"2009","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"14","key":"10.1016\/j.intimp.2022.108682_b0755","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0161-5890(02)00030-5","article-title":"A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors","volume":"38","author":"Boyington","year":"2002","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0760","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.184.4.1585","article-title":"A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B* 2705","volume":"184","author":"Peruzzi","year":"1996","journal-title":"J. Exp. Med."},{"issue":"5200","key":"10.1016\/j.intimp.2022.108682_b0765","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1126\/science.7863326","article-title":"Peptide specificity in the recognition of MHC class I by natural killer cell clones","volume":"267","author":"Malnati","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.intimp.2022.108682_b0770","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fimmu.2012.00339","article-title":"New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease","volume":"3","author":"Shaw","year":"2012","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0775","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.27332","article-title":"Association of the KIR3DS1* 013 and KIR3DL1* 004 alleles with susceptibility to ankylosing spondylitis","volume":"62","author":"D\u00edaz-Pe\u00f1a","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar1988","article-title":"Contribution of KIR3DL1\/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations","volume":"8","author":"Lopez-Larrea","year":"2006","journal-title":"Arthritis research & therapy"},{"key":"10.1016\/j.intimp.2022.108682_b0785","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/ddr.21187","article-title":"Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis","volume":"75","author":"Cauli","year":"2014","journal-title":"Drug Dev. Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0790","first-page":"88","article-title":"Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis","volume":"7","author":"Mousavi","year":"2010","journal-title":"Iranian Journal of Immunology"},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0795","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/s10165-012-0692-z","article-title":"Association of KIR genotype with susceptibility to HLA-B27-positive ankylosing spondylitis","volume":"23","author":"Wang","year":"2013","journal-title":"Mod. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8146","article-title":"Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1","volume":"6","author":"Cortes","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0805","first-page":"567","volume":"24","author":"Ebrazeh","year":"2021","journal-title":"Association of the genetic variants in the endoplasmic reticulum aminopeptidase 2 gene with ankylosing spondylitis susceptibility, International journal of rheumatic diseases"},{"key":"10.1016\/j.intimp.2022.108682_b0810","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.imlet.2020.04.015","article-title":"Endoplasmic reticulum aminopeptidase 2 gene single nucleotide polymorphisms in association with susceptibility to ankylosing spondylitis in an Iranian population","volume":"223","author":"Ebrazeh","year":"2020","journal-title":"Immunol Lett"},{"key":"10.1016\/j.intimp.2022.108682_b0815","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2020.02.020","article-title":"The roles of ERAP1 and ERAP2 in autoimmunity and cancer immunity: new insights and perspective","volume":"121","author":"Babaie","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2022.108682_b0820","doi-asserted-by":"crossref","first-page":"464","DOI":"10.18502\/ijaai.v17i5.304","article-title":"Evaluation of ERAP1 gene single nucleotide polymorphism in impressing the inflammatory cytokine profile of ankylosing spondylitis patients","author":"Mohammadi","year":"2018","journal-title":"Iranian Journal of Allergy, Asthma and Immunology"},{"key":"10.1016\/j.intimp.2022.108682_b0825","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2018.11.002","article-title":"Association analysis of ERAP1 gene single nucleotide polymorphism in susceptibility to ankylosing spondylitis in Iranian population","volume":"201","author":"Babaie","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2022.108682_b0830","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2019.10.016","article-title":"Evaluation of ERAP1 gene single nucleotide polymorphisms in immunomodulation of pro-inflammatory and anti-inflammatory cytokines profile in ankylosing spondylitis","volume":"217","author":"Babaie","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2022.108682_b0835","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.imlet.2020.04.015","article-title":"Endoplasmic reticulum aminopeptidase 2 gene single nucleotide polymorphisms in association with susceptibility to ankylosing spondylitis in an Iranian population","volume":"223","author":"Ebrazeh","year":"2020","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0840","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000597","article-title":"Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis","volume":"4","author":"Cauli","year":"2018","journal-title":"RMD open"},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0845","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/annrheumdis-2015-208677","article-title":"Genetic association of ankylosing spondylitis with TBX21 influences T-bet and pro-inflammatory cytokine expression in humans and SKG mice as a model of spondyloarthritis","volume":"76","author":"Lau","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0850","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02284064","volume":"7","author":"Thoen","year":"1988","journal-title":"Clin. Rheumatol."},{"issue":"8","key":"10.1016\/j.intimp.2022.108682_b0855","first-page":"888","article-title":"Natural cytotoxic function and ankylosing spondylitis","volume":"37","author":"Wendling","year":"1989","journal-title":"Pathologie-biologie"},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0860","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-018-1692-y","article-title":"An explorative study on deep profiling of peripheral leukocytes to identify predictors for responsiveness to anti-tumour necrosis factor alpha therapies in ankylosing spondylitis: natural killer cells in focus","volume":"20","author":"Schulte-Wrede","year":"2018","journal-title":"Arthritis research & therapy"},{"key":"10.1016\/j.intimp.2022.108682_b0865","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fimmu.2015.00134","article-title":"Beh\u00e7et\u2019s disease: do natural killer cells play a significant role?","volume":"6","author":"Petrushkin","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2049-6958-8-29","article-title":"Pulmonary manifestations in Beh\u00e7et disease: impaired natural killer cells activity","volume":"8","author":"Hamzaoui","year":"2013","journal-title":"Multidisciplinary respiratory medicine"},{"key":"10.1016\/j.intimp.2022.108682_b0875","first-page":"413","article-title":"Pathogenesis of Beh\u00e7et\u2019s disease: autoinflammatory features and beyond, Seminars in immunopathology","author":"G\u00fcl","year":"2015","journal-title":"Springer"},{"key":"10.1016\/j.intimp.2022.108682_b0880","doi-asserted-by":"crossref","unstructured":"F. Esen, \u00d6. T\u00dcRKYILMAZ, V. Aykut, H. Direskeneli, G. Deniz, H. O\u011fuz, E.\u00c7. AKTA\u015e, Influence of \u0130nterferon \u03b1-2a Treatment on Monocyte Subsets in Patients with Uveitis, Turk J Immunol 8(2) (2020) 50-56.","DOI":"10.25002\/tji.2020.1261"},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0885","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1167\/iovs.18-25548","article-title":"Effect of interferon alfa-2a treatment on adaptive and innate immune systems in patients with Beh\u00e7et disease uveitis","volume":"60","author":"Albayrak","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.intimp.2022.108682_b0890","unstructured":"J.C. Jennette, R. Falk, P. Bacon, N. Basu, M. Cid, F. Ferrario, L. Flores-Suarez, W. Gross, L. Guillevin, E. Hagen, 2012 revised international chapel hill consensus conference nomenclature of vasculitides, (2013)."},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0895","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2133.1985.tb02083.x","article-title":"Natural killer cell numbers and function in peripheral lymphoid cells in Behcet's disease","volume":"113","author":"Kaneko","year":"1985","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0900","first-page":"588","article-title":"Increased peripheral blood gamma delta+ T cells and natural killer cells in Behcet's disease","volume":"19","author":"Suzuki","year":"1992","journal-title":"The Journal of rheumatology"},{"key":"10.1016\/j.intimp.2022.108682_b0905","first-page":"733","article-title":"Esin Aktas Cetin, Fulya Cosan, Umut Can Kucuksezer, Sema Bilgic, Yonca","volume":"33","author":"Cagatay","year":"2013","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3005","article-title":"Natural killer cells control a T-helper 1 response in patients with Behcet's disease","volume":"12","author":"Yamaguchi","year":"2010","journal-title":"Arthritis research & therapy"},{"key":"10.1016\/j.intimp.2022.108682_b0915","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3389\/fimmu.2018.02157","article-title":"Higher frequencies of lymphocytes expressing the natural killer group 2D receptor in patients with Beh\u00e7et disease","volume":"9","author":"Bonacini","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0920","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/cei.12939","article-title":"Circulating NK cells and their subsets in Beh\u00e7et's disease","volume":"188","author":"Hasan","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"6 Suppl 94","key":"10.1016\/j.intimp.2022.108682_b0925","first-page":"S24","article-title":"Natural killer cells dominate a Th-1 polarized response in Beh\u00e7et\u2019s disease patients with uveitis","volume":"33","author":"Kucuksezer","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b0930","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/08820139.2014.886260","article-title":"Phenotypic abnormalities of peripheral blood mononuclear cells in patients with Beh\u00e7et\u2019s disease and association with HLA-B51 expression","volume":"43","author":"Sakly","year":"2014","journal-title":"Immunol. Invest."},{"issue":"9","key":"10.1016\/j.intimp.2022.108682_b0935","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","article-title":"Th1 polarization of the immune response in Beh\u00e7et's disease: A putative pathogenetic role of interleukin-12","volume":"42","author":"Frassanito","year":"1999","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b0940","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3109\/14397595.2013.879414","article-title":"IL-22-secreting Th22 and IFN-\u03b3-secreting Th17 cells in Beh\u00e7et's disease","volume":"24","author":"Aktas Cetin","year":"2014","journal-title":"Mod. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0945","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.imlet.2008.07.009","article-title":"Serum cytokine profiles in Behcet's disease: is there a role for IL-15 in pathogenesis?","volume":"121","author":"Curnow","year":"2008","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2022.108682_b0950","first-page":"S3","author":"G\u00fcl","year":"2011","journal-title":"Genome-wide association studies in Behcet's disease: expectations and promises"},{"issue":"7","key":"10.1016\/j.intimp.2022.108682_b0955","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/gene.2016.36","article-title":"Evaluation of KIR3DL1\/KIR3DS1 polymorphism in Beh\u00e7et\u2019s disease","volume":"17","author":"Erer","year":"2016","journal-title":"Genes Immun."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b0960","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1399-0039.1990.tb01802.x","article-title":"HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen-via CD8-positive suppressor T cells","volume":"36","author":"Watanabs","year":"1990","journal-title":"Tissue Antigens"},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b0965","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.187.5.813","article-title":"Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence\u2013derived peptides by CD94\/NKG2 confers protection from natural killer cell\u2013mediated lysis","volume":"187","author":"Borrego","year":"1998","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b0970","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1073\/pnas.94.4.1298","article-title":"Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease","volume":"94","author":"Mizuki","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b0975","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/cei.13419","article-title":"The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation","volume":"201","author":"Servaas","year":"2020","journal-title":"Clin. Exp. Immunol."},{"issue":"10103","key":"10.1016\/j.intimp.2022.108682_b0980","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.intimp.2022.108682_b0985","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.humimm.2018.01.003","article-title":"Epigenetics and pathogenesis of systemic sclerosis; the ins and outs","volume":"79","author":"Aslani","year":"2018","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.intimp.2022.108682_b0990","first-page":"132","article-title":"The immunobiology of systemic sclerosis, Seminars in arthritis and rheumatism","author":"Gu","year":"2008","journal-title":"Elsevier"},{"key":"10.1016\/j.intimp.2022.108682_b0995","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00281-015-0503-7","article-title":"Role of innate immune system in systemic sclerosis","author":"Fullard","year":"2015","journal-title":"Seminars in immunopathology, Springer"},{"issue":"6","key":"10.1016\/j.intimp.2022.108682_b1000","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/BOR.0b013e32834b0dac","article-title":"An update on an immune system that goes awry in systemic sclerosis","volume":"23","author":"Van Bon","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b1005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2362.1988.tb01158.x","article-title":"Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization","volume":"18","author":"Scharffetter","year":"1988","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b1010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clim.2010.06.004","article-title":"Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis: correlations with disease severity and phenotypes","volume":"137","author":"Giovannetti","year":"2010","journal-title":"Clinical immunology"},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b1015","first-page":"283","article-title":"Reduced circulating natural killer T cells and gamma\/delta T cells in patients with systemic sclerosis","volume":"32","author":"Riccieri","year":"2005","journal-title":"The Journal of rheumatology"},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b1020","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.0022-202X.2005.23767.x","article-title":"Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity","volume":"125","author":"Horikawa","year":"2005","journal-title":"J, Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b1025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/2047-783X-15-1-44","article-title":"Absolute count of T and B lymphocyte subsets is decreased in systemic sclerosis","volume":"15","author":"Gambichler","year":"2010","journal-title":"Eur. J. Med. Res."},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b1030","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/art.20216","article-title":"Association of killer cell immunoglobulin-like receptors with scleroderma","volume":"50","author":"Momot","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2022.108682_b1035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clim.2016.09.004","article-title":"The magnitude of cytokine production by stimulated CD56+ cells is associated with early stages of systemic sclerosis","volume":"173","author":"Cossu","year":"2016","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.intimp.2022.108682_b1040","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3389\/fimmu.2018.01665","article-title":"Natural killer cells exhibit a peculiar phenotypic profile in systemic sclerosis and are potent inducers of endothelial microparticles release","volume":"9","author":"Benyamine","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.108682_b1045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the TH 1\/TH 2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b1050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000328011","article-title":"Natural killer cells in psoriasis","volume":"3","author":"Tobin","year":"2011","journal-title":"J. Innate Immun."},{"issue":"11\u201312","key":"10.1016\/j.intimp.2022.108682_b1055","first-page":"1136","article-title":"Systemic and Local Increase of Granulysin Expression in Cytotoxic Lymphocytes in Severe Psoriasis","volume":"99","author":"Vi\u010di\u0107","year":"2019","journal-title":"Acta dermato-venereologica"},{"key":"10.1016\/j.intimp.2022.108682_b1060","article-title":"NK cells and psoriasis","volume":"2011","author":"Dunphy","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.intimp.2022.108682_b1065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fimmu.2020.00242","article-title":"Innate lymphocytes in psoriasis","volume":"11","author":"Polese","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.108682_b1070","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3389\/fimmu.2018.01390","article-title":"T cell hierarchy in the pathogenesis of psoriasis and associated cardiovascular comorbidities","volume":"9","author":"Casciano","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b1075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/eji.200535243","article-title":"CD56brightCD16\u2013NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation","volume":"36","author":"Ottaviani","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108682_b1080","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2133.2012.10814.x","article-title":"Peripheral natural killer cells exhibit qualitative and quantitative changes in patients with psoriasis and atopic dermatitis","volume":"166","author":"Luci","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2022.108682_b1085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clim.2015.10.004","article-title":"Natural killer cells from psoriasis vulgaris patients have reduced levels of cytotoxicity associated degranulation and cytokine production","volume":"177","author":"Dunphy","year":"2017","journal-title":"Clinical Immunology"},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b1090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2133.2009.09178.x","article-title":"Upregulation of Fas and downregulation of CD94\/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis","volume":"161","author":"Son","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2022.108682_b1095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1590\/abd1806-4841.20198188","article-title":"The role of GNLY gene polymorphisms in psoriasis pathogenesis","volume":"94","author":"Ermis","year":"2019","journal-title":"Anais brasileiros de dermatologia"},{"key":"10.1016\/j.intimp.2022.108682_b1100","first-page":"14","article-title":"Assessment of perforin expression in peripheral blood lymphocytes in psoriatic patients during exacerbation of disease","volume":"211","author":"Prpi\u0107","year":"2000","journal-title":"Acta Derm. Venereol. Suppl."},{"issue":"1","key":"10.1016\/j.intimp.2022.108682_b1105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jdermsci.2007.02.007","article-title":"Analysis of perforin expression in peripheral blood and lesions in severe and mild psoriasis","volume":"47","author":"Massari","year":"2007","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2022.108682_b1110","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.4049\/jimmunol.0902518","article-title":"CD56highCD16\u2212 CD62L\u2212 NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses","volume":"184","author":"Carbone","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.108682_b1115","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.21007","article-title":"Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL\/lpr mice","volume":"52","author":"Inoue","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2022.108682_b1120","doi-asserted-by":"crossref","unstructured":"J.K. Ahn, H.G. Yu, H. Chung, Y.G. Park, Intraocular cytokine environment in active Beh\u00e7et uveitis, American journal of ophthalmology 142(3) (2006) 429-434. e1.","DOI":"10.1016\/j.ajo.2006.04.016"},{"issue":"10","key":"10.1016\/j.intimp.2022.108682_b1125","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/exd.12233","article-title":"Deletion of the activating NKG 2C receptor and a functional polymorphism in its ligand HLA-E in psoriasis susceptibility","volume":"22","author":"Zeng","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2022.108682_b1130","first-page":"1","article-title":"Assessment of the Relationship between Clinical Variants of Psoriasis and Killer Immunoglobulin-like Receptor (KIR) Genes: A Systematic Review with Meta-analysis","author":"Mac\u00edas-Barrag\u00e1n","year":"2020","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.intimp.2022.108682_b1135","doi-asserted-by":"crossref","unstructured":"C. Barranco, The future is CD56-bright, Nature Reviews Rheumatology 12(11) (2016) 624-624.","DOI":"10.1038\/nrrheum.2016.168"},{"issue":"9","key":"10.1016\/j.intimp.2022.108682_b1140","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00251-001-0392-x","article-title":"MICA genetic polymorphism and linkage disequilibrium with HLA-B in 29 African-American families","volume":"53","author":"Tian","year":"2001","journal-title":"Immunogenetics"},{"issue":"7","key":"10.1016\/j.intimp.2022.108682_b1145","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.humimm.2009.04.005","article-title":"MICA-HLA-B haplotype diversity and linkage disequilibrium in a population of Jewish descent from Majorca (the Balearic Islands)","volume":"70","author":"Cambra","year":"2009","journal-title":"Hum. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.108682_b1150","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/exd.12280","article-title":"NKG 2C, HLA-E and their association with psoriasis","volume":"22","author":"Patel","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2022.108682_b1155","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fimmu.2019.00502","article-title":"Cell-free DNA as a biomarker in autoimmune rheumatic diseases","volume":"10","author":"Duvvuri","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.108682_b1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108449","article-title":"Significance of KIR like natural killer cell receptors in autoimmune disorders","volume":"216","author":"Agrawal","year":"2020","journal-title":"Clinical Immunology"},{"issue":"7373","key":"10.1016\/j.intimp.2022.108682_b1165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nature10517","article-title":"Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B","volume":"479","author":"Vivian","year":"2011","journal-title":"Nature"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922001667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922001667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:40:18Z","timestamp":1761586818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922001667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":233,"alternative-id":["S1567576922001667"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108682","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NK cells - Dr. Jekyll and Mr. Hyde in autoimmune rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108682"}}